ArticleJournal of cancer research and clinical oncology2023

Comparative analysis of rituximab or obinutuzumab combined with CHOP in first-line treatment of follicular lymphoma.

Gwladys Claustre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.